Novo-backed $61m fundraising helps F2G prep for antifungal launchAnglo-Austrian biotech F2G has raised $60.8 million in venture financing to help it bring a drug for life-threatening Share XNovo-backed $61m fundraising helps F2G prep for antifungal launchhttps://pharmaphorum.com/news/novo-backed-61m-fundraising-helps-f2g-prep-for-antifungal-launch/
Combating Antifungal Resistance to be discussed at Superbugs & Superdrugs ConferenceAntifungal Resistance at Superbugs & Superdrugs 2019 Share XCombating Antifungal Resistance to be discussed at Superbugs & Superdrugs Conferencehttps://pharmaphorum.com/partner-content/combating-antifungal-resistance-to-be-discussed-at-superbugs-superdrugs-conference/